Niemann-Pick Disease, A Pipeline Analysis Report 2018
Por um escritor misterioso
Descrição
Technavio has published a new report on the drug development pipeline for Niemann-pick disease, including a study of the pipeline molecules.
10-K
Niemann- Pick Disease Type C (NPC) Market Report 2023-2033 - Wissen Research
Signatures of natural selection and ethnic-specific prevalence of NPC1 pathogenic mutations contributing to obesity and Niemann–Pick disease type C1
The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells
Niemann–Pick disease type C Therapeutics Market - NPC Therapeutics Market
Frontiers Case Report: Be Aware of “New” Features of Niemann–Pick Disease: Insights From Two Pediatric Cases
Rapid Diagnosis of 83 Patients with Niemann Pick Type C Disease and Related Cholesterol Transport Disorders by Cholestantriol Screening - eBioMedicine
Cells, Free Full-Text
Cells, Free Full-Text
Orphazyme's arimoclomol to be used with Zavesca after FDA approval
Full article: Current advancements in therapy for Niemann-Pick disease: progress and pitfalls
Current Clinical Applications of In Vivo Gene Therapy with AAVs: Molecular Therapy
Metabolic Therapeutics - Pharma Proff
Prader-Willi Syndrome, A Drug Pipeline Analysis Report 2018, Technavio
Biomarker analysis of Niemann-Pick disease type C using chromatography and mass spectrometry - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
